Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001829126-25-003834
Filing Date
2025-05-20
Accepted
2025-05-20 16:05:37
Documents
44
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bodhitreebiotech_10q.htm   iXBRL 10-Q 349711
2 EXHIBIT 31.1 bodhitreebiotech_ex31-1.htm EX-31.1 13724
3 EXHIBIT 31.2 bodhitreebiotech_ex31-2.htm EX-31.2 13722
4 EXHIBIT 32.1 bodhitreebiotech_ex32-1.htm EX-32.1 5734
5 EXHIBIT 32.2 bodhitreebiotech_ex32-2.htm EX-32.2 5703
  Complete submission text file 0001829126-25-003834.txt   1921297

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE cik0002041531-20250331.xsd EX-101.SCH 19739
7 XBRL CALCULATION FILE cik0002041531-20250331_cal.xml EX-101.CAL 21883
8 XBRL DEFINITION FILE cik0002041531-20250331_def.xml EX-101.DEF 23428
9 XBRL LABEL FILE cik0002041531-20250331_lab.xml EX-101.LAB 169395
10 XBRL PRESENTATION FILE cik0002041531-20250331_pre.xml EX-101.PRE 131787
46 EXTRACTED XBRL INSTANCE DOCUMENT bodhitreebiotech_10q_htm.xml XML 169390
Mailing Address 4125 BLACKHAWK PLAZA CIRCLE, SUITE 172 DANVILLE CA 94506
Business Address 4125 BLACKHAWK PLAZA CIRCLE, SUITE 172 DANVILLE CA 94506 (925)406-4528
Bodhi Tree Biotechnology Inc (Filer) CIK: 0002041531 (see all company filings)

EIN.: 934908449 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 333-284678 | Film No.: 25968720
SIC: 8742 Services-Management Consulting Services
(CF Office: 07 Trade & Services)